Daniel Willis, MD MPHS  dwillis22@wustl.edu

Profile picture
Assistant Professor of Pediatrics, Hematology and Oncology
Hematology and Oncology

phone: (314) 454-6018

Clinical Interests

Dr Willis is a clinical oncologist in the Division of Pediatric Hematology/Oncology. Areas of clinical interest include solid tumors including neuroblastoma retinoblastoma, and melanoma. He aids in the operations of the Intra-Arterial Chemotherapy for Retinoblastoma and Neuroblastoma MIBG treatment programs. Dr Willis's research interests focus on infection prevention in oncology patients and he conducts research on the risk factors and prevention of bacteremia and C. difficile infections.


  • BA, Benedictine College2009
  • MD, University of Kansas School of Medicine2013
  • MS, Washington University in St. Louis2019


  • Resident, St. Louis Children's Hospital2013 - 2016
  • Clinical Fellow, Washington University School of Medicine2016 - 2019
  • Basic Certificate in Quality and Safety, Institute for Healthcare Improvement2020 - 2021
  • 2020 Pediatric Leadership Development Program, Washington University School of Medicine2020 - 2020

Licensure and Board Certification

  • 2016 - PresMO, Missouri Medical License
  • 2016 - PresBoard Certification, General Pediatrics
  • 2021 - PresBoard Certification, Pediatric Hematology Oncology

Recent Publications view all (5)

Publication Co-Authors

  1. Failure modes and effects analysis of pediatric i‐131 mibg therapy: program design and potential pitfalls Pediatric Blood and Cancer. 2022. doi:10.1002/pbc.29996  
  2. Minimum Volume Standards for Surgical Care of Early-Stage Lung Cancer: A Cost-Effectiveness Analysis Ann Thoracic Surg. 2022. doi:https://doi.org/10.1016/j.athoracsur.2022.06.017  PMID:35780816 
  3. Wilms Tumor in Patients with Osteopathia Striata with Cranial Sclerosis European Journal of Human Genetics. 2020. doi:10.1038/s41431-020-00718-4  PMID:32879452 
  4. Expanding the Clinical and Genetic Spectrum of CAD-deficiency – an epileptic encephalopathy treatable with uridine supplementation Genetics in Medicine. 2020. doi:https://doi.org/10.1038/s41436-020-0933-z  PMID:32820246 
  5. Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes Journal of the Pediatric Infectious Disease Society. 2020. doi:10.1093/jpids/piaa090  PMID:32766672 
Last updated: 09/15/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130